CME

CME Group
D

CME

Arincen73/100B

CME Group financials

Yes. CME Group earned 4.40B USD of net income over the last twelve months, 63.1% of its revenue. It made a profit in 25 of its 26 fiscal years since 2000. Its last loss was in fiscal year 2000.

Revenue (TTM)
6.97B USD
Net income (TTM)
4.40B USD
Free cash flow (TTM)
4.33B USD
Cash and short-term investments
2.33B USD
Total debt
3.43B USD
Shareholders' equity
26.56B USD

Cash, debt and equity as of 30 Sept 2026.

CME Group earnings

Next earnings · Q4 FY2026
EPS estimate
3.01 USD
Revenue estimate
1.76B USD
Last quarter · Q3 FY2026
EPS3.02Beat +1.0%Revenue1.74BBeat +1.3%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20283.55———1.94B———
Q2 FY20283.54———1.94B———
Q1 FY20283.69———2.00B———
Q4 FY20263.01——+8.66%1.76B——+6.89%
Q3 FY20262.993.02+1.00%+12.69%1.71B1.74B+1.31%+12.99%
Q2 FY20262.912.99+2.75%+1.01%1.68B1.71B+1.43%+0.84%
Q1 FY20263.343.36+0.60%+20.00%1.87B1.88B+0.28%+14.48%
Q4 FY20252.752.77+0.73%+9.92%1.65B1.65B+0.09%+8.09%
Q3 FY20252.632.68+1.90%0.00%1.53B1.54B+0.49%-2.95%
Q2 FY20252.912.96+1.72%+15.63%1.69B1.69B+0.38%+10.41%

CME Group growth and profitability

Full income statement
Revenue (TTM)
6.97B USD
Net income (TTM)
4.40B USD
Gross margin
84.32%
Operating margin
65.66%
Net margin
63.12%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY20256.52B+6.37%4.04B+14.71%86.09%64.86%62.02%5.78B+14.63%
FY20246.13B+9.88%3.53B+9.29%86.13%64.13%57.52%5.04B+8.01%
FY20235.58B+11.15%3.23B+19.89%85.15%61.58%57.83%4.67B+16.19%
FY20225.02B+7.03%2.69B+2.07%85.00%60.08%53.61%4.02B+2.28%
FY20214.69B-3.97%2.64B+25.23%82.15%56.40%56.22%3.93B+17.10%

How CME Group makes its money

clearing and transaction fees5.28B 81.0%
MarketData803.10M 12.3%
OtherRevenue436.40M 6.7%
Revenue6.52B 100.0%
Cost of revenue907.00M 13.9%
Gross profit5.61B 86.1%
Selling and administration150.50M 2.3%
Other operating expenses1.23B 18.9%
Operating income4.23B 64.9%
Tax1.27B 19.5%
Net income4.04B 62.0%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

CME Group revenue breakdown

By product

FY2025
clearing and transaction fees: 81.0%MarketData: 12.3%OtherRevenue: 6.7%81.0%clearing and transaction fees12.3%MarketData6.7%OtherRevenue
SegmentRevenueShare of revenueChange on the year
clearing and transaction fees5.28B81.0%+5.9%
MarketData803.10M12.3%+13.1%
OtherRevenue436.40M6.7%+1.1%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY20254.28B4.19B
FY20243.69B3.60B
FY20233.45B3.38B
FY20223.06B2.97B
FY20212.40B2.28B
FY20202.72B2.52B
FY20192.67B2.43B
FY20182.44B2.32B
FY20171.84B1.76B
FY20161.72B1.62B

CME Group financial health

Full balance sheet
Cash and short-term investments
2.33B USD
Total debt
3.43B USD
Net cash
-1.10B USD
Free cash flow (TTM)
4.33B USD
Current ratio
1.02
Debt to equity
0.13
Piotroski score
6 / 9
Altman Z-score
0.60

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20254.54B3.42B4.19B
FY20243.01B3.43B3.60B
FY20233.02B3.43B3.38B
FY20222.82B3.44B2.97B
FY20212.95B3.45B2.28B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY2025198.42B169.70B28.73B
FY2024137.45B110.96B26.49B
FY2023129.71B102.97B26.74B
FY2022174.18B147.30B26.88B
FY2021196.78B169.38B27.40B
FY2020124.66B98.31B26.32B
FY201975.22B49.06B26.13B
FY201877.48B51.51B25.92B
FY201775.79B53.38B22.41B
FY201669.37B49.03B20.34B

CME Group valuation

Price to earnings ratio (TTM)
26.04
Forward P/E (FY2026)
25.75
Price to sales (TTM)
16.39
Price to book
4.30
EV / EBITDA (TTM)
17.40

Capital structure

Market capitalization
114.28B USD
+
Total debt
3.43B USD
−
Cash and short-term investments
2.33B USD
=
Enterprise value
115.38B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)22.38————
FY2027 (est.)24.1022.38———
FY2026 (est.)25.7524.10———
Now (TTM)26.0424.3016.394.3017.40
FY202524.4322.0315.063.4216.83
FY202423.9720.7913.613.1516.67
FY202323.7420.6913.552.8316.32
FY202222.6918.1812.022.2415.20
FY202131.3028.7917.462.9921.01

CME Group against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: Intercontinental Exchange, Moody's, S&P Global, Nasdaq, MSCI, and Coinbase Global, the US Financial - Data & Stock Exchanges companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median26.0
    18.536.7
  • Gross marginAbove its median86.1%
    82.2%86.1%
    Against its peers: 1 of 7Peers' median 69.2%
  • Operating marginHighest in 5 years64.9%
    56.4%64.9%
    Against its peers: 1 of 7Peers' median 40.5%
  • Net marginHighest in 5 years62.0%
    53.6%62.0%
    Against its peers: 1 of 7Peers' median 27.6%
  • Return on equityHighest in 5 years14.1%
    9.6%14.1%
    Against its peers: 4 of 6Peers' median 14.3%
  • Free cash flow marginHighest in 5 years64.3%
    48.5%64.3%
    Against its peers: 1 of 7Peers' median 33.9%
  • Revenue growthBelow its median6.4%
    -4.0%11.1%
    Against its peers: 7 of 7Peers' median 9.1%
  • EPS growthAt its median15.4%
    1.5%24.2%
    Against its peers: 5 of 7Peers' median 19.7%
  • Debt to EBITDALowest in 5 years0.59×
    0.59×0.88×
    Against its peers: 1 of 7Peers' median 3.11×
  • Current ratioHighest in 5 years1.03
    1.011.03
    Against its peers: 3 of 7Peers' median 1.01

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

CME Group dividends

Annual dividend
5.20 USD
Dividend yield (indicated)
1.63%
Payout ratio
42.01%
Years of dividend growth
16
Frequency
Quarterly
Next payment
1.30 USD
Next ex-dividend date
11 Dec 2026
Next payment date
30 Dec 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share5.004.604.404.003.605.904.756.305.895.30

CME Group ownership

Institutions
90.11%
Institutional holders
1,775 (-97)
Free float
98.63%

Who owns the shares

Institutions 90.1% Others 9.9%
As of 30 Jun 2026

Shares free to trade

Free float 353.02M shares ·98.6% Closely held 4.92M shares ·1.4%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 2026040.0017.48K
Q3 20261349.46K28.47K
Q2 20262339.01K65.70K
Q1 202627125.68K73.83K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025359.63M360.23M+0.08%
FY2024359.39M359.94M+0.12%
FY2023359.02M359.50M+0.09%
FY2022358.71M359.18M+0.07%
FY2021358.34M358.93M+0.11%

Common questions about CME Group's financials

Source: Financial Modeling Prep